Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z F Jiang

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 20, 2020
[The present situation and future of real world research in diagnosis and treatment of breast cancer]Z F Jiang, F R Xu
Zhonghua Yi Xue Za Zhi|May 28, 2026
[Key points and interpretation of Chinese expert's consensus on endocrine therapy of breast cancer (2026 edition)]S H Zhang, Z F Jiang
Zhonghua Yi Xue Za Zhi|February 11, 2020
[Ten hot issues of breast cancer under the novel coronavirus]Z F Jiang, J B Li
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 6, 2018
[Ten hot issues of breast cancer in diagnosis and therapy in 2018]Z F Jiang, J B Li
Human & Experimental Toxicology|June 5, 2020
MicroRNA: Potential biomarker and target of therapy in acute lung injuryZ-F Jiang, L Zhang, J Shen
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 2, 2019
[Cold thinking in the boom of artificial intelligence]Z F Jiang, F Li, F R Xu
Shi Yan Sheng Wu Xue Bao|June 1, 1997
[Nuclear reconstitution around purified E. coli DNA in cell-free extracts of Xenopus laevis eggs]Z F Jiang, J Qu, Z H Zhai
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 31, 2023
[Development in the last 20 years of anti-HER2 targeted therapy for breast cancer]B Liu, J B Li, Z F Jiang
Life Sciences|December 17, 2017
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancerZ F Jiang, M Wang, J L Xu
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 28, 2020
[Expert consensus on the management of adverse events of ErbB family tyrosine kinase inhibitors in breast cancer]B Y Wang, R Ge, Z F Jiang, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 20, 2020
[The present situation and future of real world research in diagnosis and treatment of breast cancer]Z F Jiang, F R Xu
Zhonghua Yi Xue Za Zhi|May 28, 2026
[Key points and interpretation of Chinese expert's consensus on endocrine therapy of breast cancer (2026 edition)]S H Zhang, Z F Jiang
Zhonghua Yi Xue Za Zhi|February 11, 2020
[Ten hot issues of breast cancer under the novel coronavirus]Z F Jiang, J B Li
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 6, 2018
[Ten hot issues of breast cancer in diagnosis and therapy in 2018]Z F Jiang, J B Li
Human & Experimental Toxicology|June 5, 2020
MicroRNA: Potential biomarker and target of therapy in acute lung injuryZ-F Jiang, L Zhang, J Shen
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 2, 2019
[Cold thinking in the boom of artificial intelligence]Z F Jiang, F Li, F R Xu
Shi Yan Sheng Wu Xue Bao|June 1, 1997
[Nuclear reconstitution around purified E. coli DNA in cell-free extracts of Xenopus laevis eggs]Z F Jiang, J Qu, Z H Zhai
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 31, 2023
[Development in the last 20 years of anti-HER2 targeted therapy for breast cancer]B Liu, J B Li, Z F Jiang
Life Sciences|December 17, 2017
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancerZ F Jiang, M Wang, J L Xu
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 28, 2020
[Expert consensus on the management of adverse events of ErbB family tyrosine kinase inhibitors in breast cancer]B Y Wang, R Ge, Z F Jiang, et al.
Pageof 7